Biography
Akos Herzeg, MD, PhD, MBA - Research Fellow is a German/Hungarian Maternal-Fetal Medicine specialist and a fetal surgeon. He is the inaugural senior fellow in the MacKenzie Lab and UCSF Center for Maternal-Fetal Precision Medicine where he is working closely with Tippi Mackenzie, on clinical applications of fetal molecular therapies: fetal gene therapies and fetal enzyme replacement therapies. Akos has trained in prenatal medicine and fetal therapy at the University of Heidelberg in Germany where he has led the development and clinical oversight of the Center for Fetal Surgery. His expertise includes managing complicated monochorionic twins, complex multiple gestations, high-risk pregnancies, and fetal Spinal dysraphisms. He also holds an MBA in Healthcare Administration with a concentration in the Management of Centers of Healthcare Excellence and is currently the Chief Strategy Officer of the UCSF Broad Stem Cell Center.
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Alumni Scholarship | Frankfurt School of Finance and Management | 2017/2019 |
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
MIT | Artificial Intelligence in Healthcare | 12/2022 | |
Frankfurt School of Finance and Management | MBA | Healthcare Business Administration | 05/2019 |
Heidelberg University | Fellowship Maternal Fetal Medicine | 07/2017 | |
Heidelberg University | OBGYN Specialist | 07/2015 | |
Heidelberg University | PhD | Molecular Biology | 06/2015 |
UCSF | Postdoc Research Epidermal Stem Cells | 05/2010 | |
Hatieganu Medical University | MD | Medicine | 09/2007 |
Semmelweis University | MD | Medicine | 09/2007 |
Publications
- The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review.| | PubMed
- Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus.| | PubMed
- Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects.| | PubMed
- Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting).| | PubMed
- The impact of a short cervix and funneling on the outcome in singleton pregnancies treated with an Arabin-pessary or a McDonald cerclage.| | PubMed
- Combined treatment of McDonald cerclage and Arabin-pessary: a chance in the prevention of spontaneous preterm birth?| | PubMed
- Comparative animal study of the antinociceptive efficacy of lamotrigine and gabapentin for the management of pain.| | PubMed
- S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.| | PubMed
- Timing of elective repeat caesarean does matter: Importance of avoiding early-term delivery especially in diabetic patients.| | PubMed
- Breast cancer mastectomy trends between 2006 and 2010: association with magnetic resonance imaging, immediate breast reconstruction, and hospital volume.| | PubMed
- The CD44+ ALDH+ population of human keratinocytes is enriched for epidermal stem cells with long-term repopulating ability.| | PubMed
- Subclinical depressive symptoms during pregnancy and birth outcome--a pilot study in a healthy German sample.| | PubMed